CYP1A1 metabolizes multiple exogenous and endogenous substrates, which is mainly controlled by the aryl hydrocarbon receptor (AHR) and has been found to be involved in lung disease including COPD by regulating inflammation and oxidative stress [30–32]. The gene discussed is AHR; the disease is chronic obstructive pulmonary disease.